2.1. Pterostilbene Was Predicted to Sensitize Cisplatin-Resistant Bladder Cancer Cells with HRAS Gene Alterations via RAS-Related Autophagy and Cell Senescence Pathways. The gene discussed is HRAS; the disease is urinary bladder carcinoma.